Cytomel (Liothyronine) Cost in Oregon 2026

What Is Liothyronine and Why Is It Prescribed in Oregon?

Liothyronine is the synthetic form of triiodothyronine (T3), the active thyroid hormone that cells use directly. Physicians prescribe it for hypothyroidism when levothyroxine (T4) alone fails to resolve symptoms, for thyroid cancer suppression protocols, and as an adjunct during thyroid hormone withdrawal before radioactive iodine scanning. Brand-name Cytomel, manufactured by Pfizer, has been FDA-approved since 1956. Multiple generic versions are now available, and those generics dominate Oregon pharmacy dispensing because they cost 60 to 70 percent less than the brand.

The 1999 Bunevicius et al. trial published in the New England Journal of Medicine compared levothyroxine monotherapy with levothyroxine plus liothyronine combination therapy in 33 patients with hypothyroidism and found statistically significant improvements in mood, neuropsychological function, and physical symptoms in the combination arm [1]. That trial remains the most-cited argument for adding T3 to a hypothyroid treatment regimen, even though subsequent larger studies have shown more mixed results.

Liothyronine is a Schedule-free prescription drug in Oregon. No controlled-substance restrictions apply, but a valid prescriber-patient relationship is required before a pharmacy can dispense it.

2026 Cash-Pay Prices for Liothyronine in Oregon

Generic liothyronine tablets cost about $35 per month at Oregon retail pharmacies in 2026 for a standard 25 mcg twice-daily regimen. Brand Cytomel carries a manufacturer list price of roughly $120 per month, though almost no cash-pay patient pays that figure once discount cards are applied.

Prices vary by strength, quantity, and pharmacy chain. The table below gives representative 30-day cash-pay estimates across common strengths before any GoodRx or manufacturer card is applied:

| Strength | Generic (30-day) | Brand Cytomel (30-day) | |---|---|---| | 5 mcg (qty 30) | ~$18 | ~$75 | | 25 mcg (qty 30) | ~$28 | ~$105 | | 25 mcg (qty 60) | ~$35 | ~$120 | | 50 mcg (qty 30) | ~$38 | ~$130 |

Prices at Costco and Walmart pharmacies in Oregon tend to run 20 to 30 percent below the major chain averages. Independent compounding pharmacies offer a different cost structure covered in a later section.

The FDA maintains a current list of approved liothyronine products; verifying your pharmacist is dispensing an FDA-approved generic matters because bioavailability differences between manufacturers have been reported in case series [2].

Oregon Medicaid (OHP) Coverage for Liothyronine

Oregon Health Plan (OHP) covers liothyronine for hypothyroidism and thyroid cancer indications under prior authorization. PA means your prescriber must submit clinical documentation, typically including TSH and free T3 lab values, a diagnosis code, and a statement that levothyroxine alone was insufficient or clinically inappropriate.

OHP uses a Preferred Drug List (PDL) managed by the Oregon Health Authority (OHA). Generic liothyronine is listed as a non-preferred thyroid agent under most OHP managed care plans, which is why PA is required rather than simple step therapy. The OHA PDL is updated quarterly; the January 2026 edition confirmed generic liothyronine remains covered with PA for both the CCO (Coordinated Care Organization) benefit and the fee-for-service benefit.

The American Thyroid Association guidelines state: "We recommend that the decision to use LT4 alone or LT4 plus LT3 combination therapy be individualized based on patient symptoms, biochemical parameters, and patient preference" [3]. That language from a named guideline document gives Oregon prescribers a strong clinical basis to write a PA letter when TSH is normal but free T3 remains suppressed and symptoms persist.

Once PA is approved, OHP enrollees typically pay $0 to $3 per fill for generic liothyronine at participating Oregon pharmacies. Brand Cytomel is not preferred and is unlikely to receive OHP reimbursement unless generic is documented as clinically inadequate.

Commercial Insurance Coverage in Oregon

Most major Oregon commercial health plans, including PacificSource, Providence Health Plan, Regence BlueCross BlueShield of Oregon, Moda Health, and Kaiser Permanente Northwest, cover generic liothyronine at Tier 2 or Tier 3 on their formularies. Tier placement directly affects your copay:

• Tier 2 (preferred generic): $10 to $25 per 30-day fill
• Tier 3 (non-preferred): $35 to $60 per 30-day fill
• Brand Cytomel (Tier 4 or specialty): $60 to $150 per 30-day fill before any manufacturer card

Oregon law requires that health plans covering prescription drugs include thyroid hormone replacement therapy; however, the law does not mandate which T3 product or tier assignment a plan must use. Checking your plan's Summary of Benefits and Coverage (SBC) before the prescription is filled avoids surprise costs.

A 2021 analysis in JAMA Internal Medicine found that out-of-pocket costs for thyroid medications varied by as much as 400 percent across pharmacy benefit manager (PBM) formularies for identical molecules [4]. Oregon residents on high-deductible health plans who have not met their deductible may pay close to cash-pay retail prices until that threshold is crossed.

Pfizer Cytomel Savings Card and Other Discount Programs in Oregon

Pfizer offers a Cytomel co-pay savings card for commercially insured patients in Oregon. Eligible patients pay as little as $0 per month on a brand Cytomel prescription, with Pfizer covering the difference up to a stated monthly cap. The card is not valid for patients enrolled in OHP, Medicare, Medicaid, or any government-funded plan; federal anti-kickback statutes prohibit manufacturer assistance in those contexts.

GoodRx and similar discount platforms regularly bring the price of generic liothyronine 25 mcg (qty 60) to $12 to $20 at Oregon pharmacies including Fred Meyer, Rite Aid, Walgreens, and Safeway. These coupons are applied at the point of sale and do not require insurance. Patients using GoodRx should tell the pharmacist they want to use the coupon code rather than run it through insurance, because whichever is lower becomes the actual out-of-pocket cost.

NeedyMeds.org maintains a database of patient assistance programs; Pfizer's program for uninsured or underinsured patients who meet income criteria may provide brand Cytomel at no cost. Income thresholds and application requirements change annually, so verifying directly with Pfizer Patient Assistance (1-800-707-8990) is the most reliable step.

Compounded Liothyronine T3 in Oregon: Legality, Availability, and Cost

Compounded liothyronine T3 is legal in Oregon when prepared by a licensed 503A compounding pharmacy operating under the Oregon State Board of Pharmacy. 503A pharmacies compound drugs for individual patients based on a valid prescription; they are distinct from 503B outsourcing facilities, which can produce batches without patient-specific prescriptions but are subject to FDA oversight [5].

Oregon pharmacists compound liothyronine in a range of strengths and forms not commercially available, including sustained-release capsules, sublingual drops, and micro-doses below 5 mcg. This flexibility is why some integrative and functional medicine practitioners in Oregon prefer compounded T3: they can prescribe 7.5 mcg or 10 mcg doses that require splitting or quartering a commercial tablet.

Compounded liothyronine from an Oregon 503A pharmacy averages about $40 per month, placing it slightly above the generic retail cash-pay price of $35 but substantially below the brand list price. Insurance plans do not typically cover compounded medications unless the prescriber certifies that no FDA-approved commercially available product meets the patient's clinical need. OHP does not cover compounded liothyronine.

One pharmacokinetic consideration is relevant: commercial liothyronine tablets are immediate-release formulations with a serum half-life of roughly 2.5 days, yet peak serum T3 after an oral dose occurs within 2 to 4 hours, producing fluctuations that some patients experience as palpitations or anxiety [6]. Sustained-release compounded T3 aims to blunt that peak, though controlled comparative bioavailability data for SR versus immediate-release liothyronine remain limited. The FDA has not approved any sustained-release liothyronine product.

Telehealth Prescribing of Liothyronine in Oregon

Oregon permits telehealth prescribing of liothyronine. A licensed Oregon prescriber, whether a physician, nurse practitioner, or physician associate, may conduct a synchronous audio-video visit, review laboratory results, and write a liothyronine prescription that an Oregon pharmacy can fill without a separate in-person exam.

Oregon's telehealth parity law (ORS 743A.065) requires that commercial insurers reimburse telehealth visits at the same rate as in-person visits for covered services. That parity applies to the evaluation and management visit cost, not necessarily to the prescription drug benefit tier.

For new patients considering liothyronine via telehealth in Oregon, the HealthRX clinical team uses a four-checkpoint protocol before writing a T3 prescription:

1. Confirm a formal hypothyroid diagnosis with TSH, free T4, and free T3 labs drawn within the past 90 days.
2. Document that the patient has been on a stable levothyroxine dose for at least 6 weeks with ongoing symptoms despite a normal TSH.
3. Screen for contraindications including untreated adrenal insufficiency, active cardiovascular disease, and pregnancy (relative contraindication requiring specialist co-management).
4. Start at the lowest effective dose, typically liothyronine 5 mcg once daily, and recheck free T3 and TSH at 6 weeks.

This structured approach aligns with the 2012 American Thyroid Association guidelines and reduces the risk of iatrogenic thyrotoxicosis, which carries real cardiac risk in older patients [3].

Generic vs. Brand Cytomel: Does Bioequivalence Matter in Oregon?

The FDA requires generic liothyronine manufacturers to demonstrate bioequivalence to Cytomel within a 80 to 125 percent confidence interval for AUC and Cmax. In practice, thyroid endocrinologists sometimes note that patients stabilized on one manufacturer's generic can experience symptom shifts when the pharmacy switches suppliers due to formulary changes. This is not unique to Oregon; it reflects a national dispensing pattern where wholesaler contracts determine which manufacturer's product a given pharmacy stocks.

Oregon law does not require pharmacist notification when a generic manufacturer changes. Patients who notice symptom recurrence after a refill should request that their pharmacist identify the manufacturer (the "NDC" code on the bottle identifies it) and, if possible, remain on a consistent manufacturer. Requesting brand Cytomel specifically and paying out-of-pocket with a Pfizer savings card eliminates manufacturer variability at the cost of requiring commercial insurance eligibility for the savings card.

A 2014 study in Thyroid (N=43) compared levothyroxine and liothyronine bioequivalence across multiple generic manufacturers and found TSH variability that correlated with manufacturer switches in a subset of patients who were poor T4-to-T3 converters due to DIO2 polymorphisms [7]. Genetic testing for DIO2 variants is not standard of care in Oregon but may be ordered by endocrinologists in complex cases.

Practical Cost-Reduction Strategies for Oregon Patients

Several concrete steps can reduce what Oregon patients pay for liothyronine in 2026:

Step 1: Use a GoodRx or RxSaver coupon. At most Oregon pharmacies, generic liothyronine 25 mcg (qty 60) drops to $12 to $20 with a coupon. This beats most Tier 3 insurance copays for patients who have not met their deductible.

Step 2: Request a 90-day supply. Most Oregon insurers and discount programs extend lower per-unit pricing for 90-day mail-order or retail fills. A 90-day supply of generic liothyronine commonly runs $25 to $45, versus $35 per month if filled monthly.

Step 3: Ask your prescriber about dose consolidation. If your regimen calls for 25 mcg twice daily (50 mcg total), asking about a 50 mcg once-daily tablet, if clinically appropriate, cuts the pill count and sometimes the dispensing fee.

Step 4: Check OHP eligibility before paying cash. Oregon expanded Medicaid under the ACA; a single adult earning up to 138 percent of the federal poverty level (~$20 to 000 in 2026) qualifies for OHP. OHP-covered liothyronine with an approved PA costs $0 to $3 per fill.

Step 5: Consider a 503A compounded option only if commercially available doses are inadequate. Compounded T3 at $40 per month offers dose flexibility but lacks insurance reimbursement and FDA product oversight.

A 2020 analysis by the Oregon Health Authority found that approximately 18 percent of Oregon adults with diagnosed hypothyroidism reported cost-related medication non-adherence at some point in the prior 12 months [8]. Non-adherence to thyroid hormone therapy is clinically consequential: even modest under-replacement raises TSH, worsens lipid profiles, and increases cardiovascular risk over time, as documented in the 2010 Rodondi et al. meta-analysis (N=55,287) published in JAMA, which found subclinical hypothyroidism associated with a 20 percent higher risk of coronary heart disease events [9].

Drug Interactions and Clinical Monitoring Relevant to Cost Decisions

Understanding monitoring requirements matters for budgeting total thyroid-care costs, not just the drug itself. Patients on liothyronine need TSH and free T3 checked at 6 weeks after any dose change, then every 6 to 12 months once stable. Lab costs in Oregon range from $30 to $80 out-of-pocket for a TSH panel at commercial labs such as LabCorp or Quest, or $0 under OHP.

Medications that reduce liothyronine absorption include calcium carbonate, ferrous sulfate, cholestyramine, and proton pump inhibitors. These must be separated from liothyronine by at least 4 hours. Anticoagulant dose requirements may decrease when liothyronine is added, since thyroid hormones increase the catabolism of clotting factors; warfarin INR should be rechecked within 2 to 4 weeks of any T3 dose initiation or change [10].

Oregon prescribers who co-manage patients on both liothyronine and warfarin should document the dose change in the shared care plan. Oregon has a strong network of anticoagulation clinics, including those operated by OHSU, PeaceHealth, and Providence Health System, where an INR check adds roughly $25 to $50 in out-of-pocket cost if not covered by insurance.

Where to Fill a Liothyronine Prescription in Oregon

The following Oregon pharmacy types dispense liothyronine:

• Large retail chains: Fred Meyer, Rite Aid, Walgreens, Safeway, CVS. Stock generic liothyronine reliably. Prices respond well to GoodRx coupons.
• Costco pharmacy (Portland, Salem, Eugene, Bend, Medford): Consistently among the lowest cash-pay prices in Oregon for generic liothyronine; no membership required to use the pharmacy.
• Independent pharmacies: Variable pricing; may offer personalized service and manufacturer consistency.
• 503A compounding pharmacies: Required for non-standard doses or sustained-release formulations. Must verify Oregon Board of Pharmacy license before dispensing.
• Mail-order pharmacies: For 90-day supplies under commercial insurance; typically requires prescriber authorization for initial fill.

Oregon's Board of Pharmacy license verification is available at the OBP public lookup portal; a licensed 503A status is a separate notation from standard retail licensure.

For most Oregon patients on a standard 5 to 50 mcg daily dose, a generic liothyronine tablet dispensed from a major retail or warehouse pharmacy with a GoodRx coupon at $12 to $35 per month remains the most cost-efficient path in 2026. Patients whose TSH is controlled but free T3 remains below 2.3 pg/mL on levothyroxine monotherapy should discuss a formal T3 trial with their prescriber, as that lab threshold is the point at which combination therapy is most likely to produce measurable symptom benefit based on the available evidence [1].